Eyenovia
Eyenovia is a late-stage ophthalmic biopharmaceutical company developing breakthrough treatments for front and back-of-the-eye diseases, which are made possible by the company’s transformative, high precision ophthalmic delivery platform.

Year Established: 2014
Stock Ticker: EYEN
Exchange: NASDAQ